首页 | 本学科首页   官方微博 | 高级检索  
检索        

AFP增强型四元复合体介导N-ras反义RNA抑制HepG2.2.15细胞成瘤性的研究
引用本文:梁晓红,孙汶生,马春红,孔建平,马亚斌,曹英林,刘素侠,高立芬,王晓燕,郭春.AFP增强型四元复合体介导N-ras反义RNA抑制HepG2.2.15细胞成瘤性的研究[J].中华微生物学和免疫学杂志,2004,24(4):311-314.
作者姓名:梁晓红  孙汶生  马春红  孔建平  马亚斌  曹英林  刘素侠  高立芬  王晓燕  郭春
作者单位:250012,济南,山东大学医学院免疫学研究所
基金项目:国家自然科学基金资助项目 (No.3 0 0 70 3 41),国家自然科学基金委海外青年学者合作研究基金资助项目 (No .3 0 12 80 2 3 )
摘    要:目的 观察AFP增强型四元复合体介导的N ras反义RNA转移系统对HBV转基因肝癌细胞系HepG2 .2 .15致瘤性的体内外抑制作用。方法 构建含有N ras反义RNA的AFP增强型四元复合体 ,体外瞬时转染HBV转基因HepG2 .2 .15细胞 ,流式细胞术检测转染前后N ras蛋白表达水平、细胞凋亡率及细胞周期的变化 ,同时建立稳定表达N ras反义RNA的肝癌细胞系HepG2 .2 .15 /as ras,绘制转染前后生长曲线。体内抑瘤试验分别以HepG2 .2 .15或HepG2 .2 .15 /as ras细胞制备荷瘤裸鼠模型 ,比较二者成瘤率。HepG2 .2 .15成瘤组局部瘤内注射N ras反义RNA四元复合体 ,研究其对肿瘤的抑制作用。结果 AFP增强型四元复合体介导N ras反义RNA体外瞬时转染HepG2 .2 .15细胞可显著降低胞内N ras蛋白的表达水平 (P <0 .0 5 ) ,使细胞生长停滞于G0 /G1期 ,且可诱导细胞凋亡。体内抑瘤实验显示 ,HepG2 .2 .15 /as ras细胞注射组成瘤率 ( 4 0 % )显著低于HepG2 .2 .15细胞注射组( 10 0 % )。瘤内注射N ras反义RNA四元复合体可使肿瘤体积明显缩小。结论 AFP增强型四元复合体介导的N ras反义RNA转移系统可降低HBV转基因肝癌细胞HepG2 .2 .15N ras蛋白的表达水平 ,逆转其恶性行为 ,体内外均可有效抑制肿瘤的生长增殖

关 键 词:肝细胞癌  N-ras癌基因  反义RNA  AFP增强型四元复合体  肝癌靶向性
修稿时间:2003年8月6日

Suppression of tumorigenicity of HepG2.2.15 cells by N-ras antisense RNA transfected with AFP-enhancing four-element complex
LIANG Xiao-hong,SUN Wen-sheng,MA Chun-hong,KONG Jian-ping,MA Ya-bin,CAO Ying-lin,LIU Su-xia,GAO Li-fen,WANG Xiao-yan,GUO Chun.Suppression of tumorigenicity of HepG2.2.15 cells by N-ras antisense RNA transfected with AFP-enhancing four-element complex[J].Chinese Journal of Microbiology and Immunology,2004,24(4):311-314.
Authors:LIANG Xiao-hong  SUN Wen-sheng  MA Chun-hong  KONG Jian-ping  MA Ya-bin  CAO Ying-lin  LIU Su-xia  GAO Li-fen  WANG Xiao-yan  GUO Chun
Institution:LIANG Xiao-hong,SUN Wen-sheng,MA Chun-hong,KONG Jian-ping,MA Ya-bin,CAO Ying-lin,LIU Su-xia,GAO Li-fen,WANG Xiao-yan,GUO Chun. Institute of Immunology,Medical School of Shandong University,Ji-nan 250012,China
Abstract:Objective To observe the inhibitory effects of N-ras antisense RNA delivered by AFP-enhancing four-element complex on tumorigenicity of HBV-transgenic hepatocellular carcinoma cell line HepG 2.2.15 both in vitro and in vivo . Methods AFP-enhancing four-element complex,containing N-ras antisense RNA, was constructed and transfected into HepG2.2.15 cells. Seventy-two hours later, cells were collected and assayed for expression of N-ras protein, cell cycle distribution and apoptosis rate by flow cytometry. In addition, HepG 2.2.15 /as-ras,stably expressing N-ras antisense RNA, was established. The growth curve of two cell lines was delineated. BALB/c nude mice were implanted with HepG2.2.15 or HepG2.2.15/as-ras cells. The tumor-forming rate for two groups were calculated. BALB/c nude mice bearing with HepG2.2.15 cells was injected with AFP-enhancing four-element complex including N-ras antisense RNA and the volumes of tumor were measured. Results After transfection by N-ras antisense RNA four-element complex, the expression of N-ras protein of HepG2.2.15 cells was greatly decreased; cell cycle was trapped at G 0/G 1 phase; apoptosis rate was enhanced. Compared with HepG2.2.15 cells, the tumor-forming rate of HepG2.2.15/as-ras cells was lower. When HepG 2.2.15 cells were implanted into nude mice, injection of N-ras antisense RNA four-element complex could significantly decrease the volume of tumor tissues. Conclusion AFP-enhancing four-element complex including N-ras antisense RNA inhibited the expression of N-ras protein and effectively impaired the tumorigenicity of HepG2.2.15 cells both in vitro and in vivo .
Keywords:Carcinoma  hepatocellular  Oncogene  N-ras  Antisense RNA  AFP-enhancing four-element complex  Hepatoma-targeted
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号